These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10635048)

  • 21. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.
    Ieven MM; Hoymans VY
    J Clin Microbiol; 2005 Jan; 43(1):19-24. PubMed ID: 15634945
    [No Abstract]   [Full Text] [Related]  

  • 22. Expression of chemokines and adhesion molecules in human coronary artery endothelial cells infected with Chlamydia (Chlamydophila) pneumoniae.
    Högdahl M; Söderlund G; Kihlström E
    APMIS; 2008 Dec; 116(12):1082-8. PubMed ID: 19133011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlamydia pneumoniae in atherosclerosis.
    Saikku P
    J Intern Med; 2000 Mar; 247(3):391-6. PubMed ID: 10762457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of human monocyte-macrophages to Chlamydia pneumoniae infection in vitro is highly variable and associated with levels of soluble CD14 and C. pneumoniae IgA and human HSP-IgG antibodies in serum.
    Poikonen K; Lajunen T; Silvennoinen-Kassinen S; Paldanius M; Leinonen M; Saikku P
    Scand J Immunol; 2008 Mar; 67(3):279-84. PubMed ID: 18194359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis.
    Fong IW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S514-8. PubMed ID: 10839750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies.
    Taylor-Robinson D; Thomas BJ
    J Clin Pathol; 1998 Nov; 51(11):793-7. PubMed ID: 10193317
    [No Abstract]   [Full Text] [Related]  

  • 27. Chlamydia in coronary plaques--hidden culprit or harmless hobo?
    Capron L
    Nat Med; 1996 Aug; 2(8):856-7. PubMed ID: 8705849
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chlamydia pneumoniae infection and atherosclerosis].
    Sumarokov AB; Liakishev AA
    Klin Med (Mosk); 1999; 77(7):4-10. PubMed ID: 10483155
    [No Abstract]   [Full Text] [Related]  

  • 29. Collaborative multidisciplinary workshop report: what questions regarding the role of Chlamydia pneumoniae in atherosclerosis and cardiovascular disease need to be addressed utilizing animal models?
    Fong IW; Quinn T; Blessing E; Kuo C; Malinverni R; Lauer M; Mawhorter S; Bachmaier K; Rosenfeld M; Taylor C; Zhong G
    J Infect Dis; 2000 Jun; 181 Suppl 3():S519-20. PubMed ID: 10839751
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibodies against Chlamydia pneumoniae predict the need for elective surgical intervention on small abdominal aortic aneurysms.
    Vammen S; Lindholt JS; Andersen PL; Henneberg EW; Østergaard L
    Eur J Vasc Endovasc Surg; 2001 Aug; 22(2):165-8. PubMed ID: 11472052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriosclerosis.
    MacInnis BJ
    Can J Ophthalmol; 1997 Jun; 32(4):217-8. PubMed ID: 9199827
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.
    Rothstein NM; Quinn TC; Madico G; Gaydos CA; Lowenstein CJ
    J Infect Dis; 2001 Jan; 183(2):232-238. PubMed ID: 11120929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Chlamydia pneumoniae have a role in atherosclerosis?
    Byers J; Robertson R
    JAAPA; 2002 May; 15(5):50-2, 55-7. PubMed ID: 12063818
    [No Abstract]   [Full Text] [Related]  

  • 34. Systemic and mucosal antibody response in experimental Chlamydia pneumoniae infection of mice.
    Penttilä T; Wahlström E; Vuola JM; Sarvas M; Puolakkainen M
    Comp Med; 2006 Aug; 56(4):272-8. PubMed ID: 16941954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chlamydia pneumoniae and arteriosclerosis: an innocent onlooker?].
    Vidal Verdú E
    An Med Interna; 1999 Jul; 16(7):329-32. PubMed ID: 10481330
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chlamydia pneumoniae and cerebrovascular disease].
    Linares-Palomino J; Gutiérrez J; López-Espada C; Ros E; Moreno J; Pérez T; Rodríguez M; Maroto MC
    Rev Neurol; 2001 Feb 1-15; 32(3):201-6. PubMed ID: 11310268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and continuous growth of Chlamydia pneumoniae from arterectomy specimens.
    Apfalter P; Loidl M; Nadrchal R; Makristathis A; Rotter M; Bergmann M; Polterauer P; Hirschl AM
    Eur J Clin Microbiol Infect Dis; 2000 Apr; 19(4):305-8. PubMed ID: 10834822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chlamydia pneumoniae in patients with atherosclerotic ischemia of the lower limbs].
    Drozdz W; Zawilińska B; Wysocki A; Kleszcz E; Wilczek M
    Przegl Lek; 2003; 60 Suppl 7():53-5. PubMed ID: 14679694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oro-dental bacteria in various atherosclerotic arteries.
    Taylor-Robinson D; Aduse-Opoku J; Sayed P; Slaney JM; Thomas BJ; Curtis MA
    Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):755-7. PubMed ID: 12415477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in antibody titers against Chlamydia pneumoniae after coronary angioplasty.
    Yetkin G; Yetkin E; Aksoy Y; Gurbuz OA; Mert A
    Int J Cardiol; 2004 Jun; 95(2-3):293-7. PubMed ID: 15193835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.